Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
APPLICATION OF ICOS+CXCR3+ REGULATORY T CELLS IN PREPARATION OF MEDICINE FOR PREVENTING SEVERE PNEUMONIA
Document Type and Number:
WIPO Patent Application WO/2021/047144
Kind Code:
A1
Abstract:
Provided are application of ICOS+CXCR3+ regulatory T cells in preparation of a medicine for preventing severe pneumonia, and the medicine for preventing pneumonia. The medicine comprises the ICOS+CXCR3+ regulatory T cells and a pharmaceutically acceptable carrier.

Inventors:
SUN LINGYUN (CN)
LI WENCHAO (CN)
CHEN WEIWEI (CN)
Application Number:
PCT/CN2020/073987
Publication Date:
March 18, 2021
Filing Date:
January 23, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
NANJING DRUM TOWER HOSPITAL (CN)
International Classes:
C12N5/0783; A61K35/17; A61P11/00
Domestic Patent References:
WO2018025221A12018-02-08
WO2013096732A22013-06-27
Foreign References:
CN107617105A2018-01-23
Other References:
BENTEBIBEL S.-E., LOPEZ S., OBERMOSER G., SCHMITT N., MUELLER C., HARROD C., FLANO E., MEJIAS A., ALBRECHT R. A., BLANKENSHIP D., : "Induction of ICOS+CXCR3+CXCR5+ TH Cells Correlates with Antibody Responses to Influenza Vaccination", SCIENCE TRANSLATIONAL MEDICINE, vol. 5, no. 176, 13 March 2013 (2013-03-13), pages 1 - 16, XP055791579, ISSN: 1946-6234, DOI: 10.1126/scitranslmed.3005191
PRIYA SAKTHIVEL; GEREKE MARCUS; BREITHAUPT ANGELE; FUCHS DIETMAR; GIGLIOTTI LUCA; GRUBER ACHIM; DIANZANI UMBERTO; BRUDER DUNJA; GU: "Attenuation of Immune-Mediated Influenza Pneumonia by Targeting the Inducible Co-Stimulator (ICOS) Molecule on T Cells", PLOS ONE, vol. 9, no. 7, 16 July 2017 (2017-07-16), pages 1 - 11, XP055255507, ISSN: 1932-6203, DOI: 10.1371/journal.pone.0100970
Attorney, Agent or Firm:
NANJING ZHONGSHAN PATENT AGENT CO., LTD. (CN)
Download PDF: